[ Price : $8.95]
FDA approves Gloucesters Istodax for treating cutaneous T-cell lymphoma in patients who have received at least one prior systemic ...[ Price : $8.95]
FDA approves a Bristol-Myers Squibb supplemental NDA for a labeling update for Reyataz (atazanavir sulfate) to include long-term d...[ Price : $8.95]
A 126-signatory letter, primarily from injured LASIK patients, asks CDRH acting director Jeffrey Shuren to issue a public health a...[ Price : $8.95]
Business Week says that a Verilogue study suggests that DTC ads are not effective in driving patients to ask doctors for specific ...[ Price : $8.95]
FDA clears a Custom Spine 510(k) for the Regent ACP, an anterior cervical plate system.[ Price : $8.95]
Federal Register Notice: FDA launches its Safe Use Initiative and releases a report on the initiative and the collaboration to red...[ Price : $8.95]
FDA grants Abraxis BioScience an orphan drug designation for its chemotherapy agent Abraxane injectable suspension, proposed for t...[ Price : $8.95]
FDA Webview posts to our site FDA inspection documents for A Major Difference Inc., Aqueous Biomedical, Colorado Reproductive Endo...